Ethical requirements of instructions for authors of complementary and alternative medicine journals: a cross-sectional study.
Complementary and alternative medicine
Instructions for authors
Integrative and complementary medicine
Medical ethics
Journal
BMC medical ethics
ISSN: 1472-6939
Titre abrégé: BMC Med Ethics
Pays: England
ID NLM: 101088680
Informations de publication
Date de publication:
13 Jul 2024
13 Jul 2024
Historique:
received:
28
08
2023
accepted:
02
07
2024
medline:
14
7
2024
pubmed:
14
7
2024
entrez:
13
7
2024
Statut:
epublish
Résumé
Medical research in complementary and alternative medicine (CAM) has increased recently, raising ethical concerns about the moral status of CAM. Medical academic journals are responsible for conducting ethical review (ER) of manuscripts to protect the interests of human subjects and to make ethical results available before deciding to publish. However, there has been no systematic analysis of the ER in CAM journals. This study is aim to evaluate the current status of ethical requirements and compliance in CAM journals. This is a cross-sectional study. We reviewed instructions for authors (IFAs) of CAM journals included in the Journal Citation Reports (2021) ( https://jcr.clarivate.com ) for general information and requirements for ER. We also browsed the manuscripts regarding randomized controlled trials published by CAM journals in Q1 and Q2 section from January to June, 2023, to check the actual situation of ethical requirement. Descriptive statistics and Fisher's exact test were used for statistical analysis. 27 journals and 68 manuscripts were ultimately included. 92.6% (25/27) IFAs included keywords of ER, indicating the presence of ethical considerations. However, no specific ER was required for CAM (n = 0). We categorized journals by Geographic origin, JCR section, Year of electronic JCR, Types of studies, % of OA Gold to explore the factors that could influence CAM journals to have certain ethical review policies. The results showed there was no statistical significance in certain ethical review policy in any classification of journals (p > 0.05). All RCT manuscripts included in the study generally met the requirements of the published journals for ethical review. All IFAs discussed ER, but the content was scattered, unfocused, and there were no specific ER requirements regarding CAM. Although the manuscripts basically met the requirements of the journal, it was not possible to get closer to the process of ER in the manuscript. To ensure full implementation of these policies in the future, CAM journals should require authors to provide more details, or to form a list of items necessary for CAM ethical review.
Sections du résumé
BACKGROUND
BACKGROUND
Medical research in complementary and alternative medicine (CAM) has increased recently, raising ethical concerns about the moral status of CAM. Medical academic journals are responsible for conducting ethical review (ER) of manuscripts to protect the interests of human subjects and to make ethical results available before deciding to publish. However, there has been no systematic analysis of the ER in CAM journals. This study is aim to evaluate the current status of ethical requirements and compliance in CAM journals.
METHODS
METHODS
This is a cross-sectional study. We reviewed instructions for authors (IFAs) of CAM journals included in the Journal Citation Reports (2021) ( https://jcr.clarivate.com ) for general information and requirements for ER. We also browsed the manuscripts regarding randomized controlled trials published by CAM journals in Q1 and Q2 section from January to June, 2023, to check the actual situation of ethical requirement. Descriptive statistics and Fisher's exact test were used for statistical analysis.
RESULTS
RESULTS
27 journals and 68 manuscripts were ultimately included. 92.6% (25/27) IFAs included keywords of ER, indicating the presence of ethical considerations. However, no specific ER was required for CAM (n = 0). We categorized journals by Geographic origin, JCR section, Year of electronic JCR, Types of studies, % of OA Gold to explore the factors that could influence CAM journals to have certain ethical review policies. The results showed there was no statistical significance in certain ethical review policy in any classification of journals (p > 0.05). All RCT manuscripts included in the study generally met the requirements of the published journals for ethical review.
CONCLUSIONS
CONCLUSIONS
All IFAs discussed ER, but the content was scattered, unfocused, and there were no specific ER requirements regarding CAM. Although the manuscripts basically met the requirements of the journal, it was not possible to get closer to the process of ER in the manuscript. To ensure full implementation of these policies in the future, CAM journals should require authors to provide more details, or to form a list of items necessary for CAM ethical review.
Identifiants
pubmed: 39003488
doi: 10.1186/s12910-024-01077-1
pii: 10.1186/s12910-024-01077-1
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
77Subventions
Organisme : Leading Talents Project of Dongzhimen Hospital
ID : 2023
Organisme : Beijing University of Chinese Medicine Project
ID : 2020TSRC-002
Informations de copyright
© 2024. The Author(s).
Références
U.S. Food and Drug Administration. 2015–2019 Drug Trials Snapshots Summary Report.[EB/OL].(2019)[2023-05-29]. https://www.fda.gov/media/143592/download?utm_medium=email&utm_source=govdelivery
World Health Organization. Number of clinical trials by year, country, WHO region and income group., (1999–2022).[EB /OL].(2023-02)[2023-05-29]. https://www.who.int/observatories/global-observatory-on-health-research-and-development/monitoring/number-of-clinical-trials-by-year-country-who-region-and-income-group
ClinicalTrials.gov Website. U.S. National Library of Medicine. https://clinicaltrials.gov/ct2/home . Accessed May 29, 2023.
Nuremberg Military Tribunal. Nuremberg Code[J] JAMA. 1996;276(20):1691.
World Medical Association declaration of Helsinki. Recommendations guiding physicians in biomedical research involving human subjects[J]. JAMA. 1997;277(11):925–6.
doi: 10.1001/jama.1997.03540350075038
Adashi EY, Walters LB, Menikoff JA. The Belmont Report at 40: reckoning with Time[J]. Am J Public Health. 2018;108(10):1345–8.
doi: 10.2105/AJPH.2018.304580
Council for International Organizations of Medical Sciences, CIOMS. International Ethical Guidelines for Health-related ResearchInvolving Humans [EB /OL].(2016)[2023-05-28]. https://www.who.int/docs/default-source/ethics/web-cioms-ethicalguidelines.pdf?sfvrsn=f62ee074_0
Ravinetto R, Singh JA. Responsible dissemination of health and medical research: some guidance points[J]. BMJ Evid Based Med. 2023;28(3):144–7.
doi: 10.1136/bmjebm-2022-111967
Kempers RD. Ethical issues in biomedical publications. Fertil Steril. 2002;77(5):883–8.
doi: 10.1016/S0015-0282(02)03076-5
Wallace MB, Siersema PD. Ethics in publication. Endoscopy. 2015;47(7):575–8.
doi: 10.1055/s-0034-1392435
International Committee of Medical Journal Editors. Journal stating that they follow the ICMJE Recommendations[EB/OL]. (2023-05)[2023-05-22]. https://www.icmje.org/news-and-editorials/updated_recommendations_may2023.html
Committee on Publication Ethics-Core practices[EB/OL]. (2017-11)[2023-05-22]. https://publicationethics.org/core-practices
Ernst E. The role of complementary and alternative medicine[J]. BMJ. 2000;321(7269):1133–5.
doi: 10.1136/bmj.321.7269.1133
Tangkiatkumjai M, Boardman H, Walker DM. Potential factors that influence usage of complementary and alternative medicine worldwide: a systematic review[J]. BMC Complement Med Ther. 2020;20:363.
doi: 10.1186/s12906-020-03157-2
World Health Organization. WHO Traditional Medicine Strategy 2014–2023[EB /OL].(2013-05-15)[2023-05-10]. https://www.who.int/publications/i/item/9789241506096
World Health Organization. The regional strategy for traditional medicine in the Western Pacific(2011–2020)[R].Manila. WHO Regional Office for the Western Pacific; 2012.
The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human. Use (ICH).ICH harmonised guideline integrated addendum to ICH E6(R1): Guideline for Good Clinical Practice ICH E6(R2).[EB /OL].(2016)[2023-05-25]. https://ichgcp.net/
Lee JE, Kang HW, Jung SA, et al. The effects of herbal medicine (Jujadokseo-hwan) on quality of life in patients with mild cognitive impairment: cost-effectiveness analysis alongside randomized controlled trial. Integr Med Res. 2023;12(1):100914.
doi: 10.1016/j.imr.2022.100914
Baklouti S, Fekih-Romdhane F, Guelmami N, et al. The effect of web-based Hatha yoga on psychological distress and sleep quality in older adults: a randomized controlled trial. Complement Ther Clin Pract. 2023;50:101715.
doi: 10.1016/j.ctcp.2022.101715
Neubert S, Schlecht S, Meng K, et al. Effects of a video sequence based intervention on anxiety, fatigue and depression in Cancer patients: results of a Randomized Controlled Trial. Integr Cancer Ther. 2023 Jan-Dec;22:15347354231153172.
Pu Z, Wen H, Jiang H, et al. Berberine improves negative symptoms and cognitive function in patients with chronic schizophrenia via anti-inflammatory effect: a randomized clinical trial. Chin Med. 2023;18(1):41.
doi: 10.1186/s13020-023-00746-4
Smith K, Ernst E, Colquhoun D, Sampson W. Complementary & alternative medicine’ (CAM): ethical and Policy Issues[J]. Bioethics. 2016;30(2):60–2.
doi: 10.1111/bioe.12243
Chow SL, Bozkurt B, Baker WL, American Heart Association Clinical Pharmacology Committee and Heart Failure and Transplantation Committee of the Council on Clinical Cardiology; Council on Epidemiology and Prevention; and Council on Cardiovascular and Stroke Nursing. Complementary and alternative Medicines in the management of Heart failure: a Scientific Statement from the American Heart Association[J]. Circulation. 2023;147(2):e4–30.
doi: 10.1161/CIR.0000000000001110
Koonrungsesomboon N, Laothavorn J, Karbwang J. Ethical considerations and challenges in first-in-human research. Transl Res. 2016;177:6–18.
doi: 10.1016/j.trsl.2016.05.006
Caspi O, Holexa J. Lack of standards in informed consent in complementary and alternative medicine. Complement Ther Med. 2005;13(2):123–30.
doi: 10.1016/j.ctim.2005.03.004
Caspi O, Shalom T, Holexa J. Informed consent in complementary and alternative medicine. Evid Based Complement Alternat Med. 2011;2011:170793.
doi: 10.1093/ecam/nep032
Chen HF, Song GH, Zhao G, Zhai WS, Sun MM, Huang ZJ, Zhang BQ, Li H, Tang JQ. Efficacy and safety of Chinese herbal medicine children’s Zibei Xuanfei syrup in treating acute trachea-bronchitis with wind-heat invading lung syndrome: a randomized, double-blind, multicentre, controlled trial. J Ethnopharmacol. 2023;309:116207.
doi: 10.1016/j.jep.2023.116207
American Medical Association. AMA Code of Medical Ethics’ opinions on informing Patients. https://journalofethics.ama-assn.org/article/ama-code-medical-ethics-opinions-informing-patients/2012-07#:~:text=Opinion%208.08%20-%20Informed%20Consent%20The%20patient%E2%80%99s%20right,make%20his%20or%20her%20own%20determination%20about%20treatment
Millum J, Grady C. The ethics of placebo-controlled trials: methodological justifications. Contemp Clin Trials. 2013;36(2):510–4.
doi: 10.1016/j.cct.2013.09.003
Howick J, Webster RK, Rees JL, Turner R, Macdonald H, Price A, Evers AWM, Bishop F, Collins GS, Bokelmann K, Hopewell S, Knottnerus A, Lamb S, Madigan C, Napadow V, Papanikitas AN, Hoffmann T. TIDieR-Placebo: a guide and checklist for reporting placebo and sham controls. PLoS Med. 2020;17(9):e1003294.
doi: 10.1371/journal.pmed.1003294
Li Y, Du P, Zhang X, Ren C, Shi X, Dong X, Zhang C. Qualified placebo for trials of herbal medicine treatment in rare diseases? A cross-sectional analysis. Orphanet J Rare Dis. 2023;18(1):373.
doi: 10.1186/s13023-023-02987-w
International Committee of Medical Journal Editors. Clinical trial registration: a statement from the International Committee of Medical Journal Editors. Lancet. 2004 Sep;11–17(9438):911–2.
De Angelis CD, Drazen JM, Frizelle FA, Haug C, Hoey J, Horton R, Kotzin S, Laine C, Marusic A, Overbeke AJ, Schroeder TV, Sox HC, Van Der Weyden MB. Is this clinical trial fully registered? A statement from the International Committee of Medical Journal Editors. Ann Intern Med. 2005;143(2):146–8.
doi: 10.7326/0003-4819-143-2-200507190-00016
Schriger DL, Arora S, Altman DG. The content of medical journal instructions for authors. Ann Emerg Med. 2006;48(6):743.
doi: 10.1016/j.annemergmed.2006.03.028
Cui C, Tian J, Song X, Yang K, Moher D, Jones A, Lepage L. Does the CONSORT checklist for abstracts improve the quality of reports of randomized controlled trials on clinical pathways? J Eval Clin PractJAMA. 20142001;20(6):827–33. CONSORT Group (Consolidated Standards for Reporting of Trials)